Ifrah Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ifrah Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,360	Closed	-$225K	–	209
2018 Q2	$225K	Sell	2,360 -4,443	-65%	-$408K	0.08%	163
2018 Q1	$597K	Sell	6,803 -62	-0.9%	-$5.66K	0.22%	88
2017 Q4	$583K	Buy	6,865 +1,990	+41%	+$167K	0.21%	91
2017 Q3	$422K	Buy	+4,875	New	+$391K	0.16%	125
2014 Q2	–	Sell	-8,520	Closed	-$405K	–	213
2014 Q1	$405K	Buy	8,520 +255	+3%	+$13.1K	0.16%	112
2013 Q4	$359K	Buy	+8,265	New	+$342K	0.14%	126

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Ifrah Financial Services's XBI Position: Q3 2018 in Review

Ifrah Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 2,360 shares — an estimated $225K sold.

Ifrah Financial Services first reported a position in XBI in Q4 2013 and held it in 6 quarters. The position peaked at $597K in Q1 2018. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

Ifrah Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
Ifrah Financial Services sold 2,360 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $225K.
Ifrah Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2013 and held it in 6 quarters.
Ifrah Financial Services's State Street SPDR S&P Biotech ETF position peaked at $597K in Q1 2018.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Ifrah Financial Services's 13F filing for Q3 2018, filed 5 Nov 2018.